cancerGRACE
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
GRACECast - What is tumor mutational burden TMB and could it be helpful in lung cancer management today 02.06.2021 5:10
Dr. Matthew Gubens joins GRACE to discuss Tumor Mutational Burden in NSCLC.
GRACECast - Treatment Options for Metastatic NSCLC 26.05.2021 9:18
Dr. Heather Wakelee joins GRACE to discuss treatment options for a metastatic non small cell lung cancer diagnosis.
GRACEcast - Are there treatment options for patients with HER-2 NSCLC 20.05.2021 5:59
Millie Das, MD Joins GRACE to discuss treatment options for patients with HER-2 NSCLC
PODCAST-GRACEcast- Dr. Sandip Patel- Emerging Molecular Targets in NSCLC- KRAS 12.05.2021 6:31
Dr. Sandip Patel discusses emerging Molecular Targets in NSCLC- KRAS
GRACEcast- Dr. Sandip Patel- Emerging Molecular Targets in NSCLC- EGFR Exon 20 05.05.2021 6:44
Dr. Sandip Patel discusses emerging molecular targets in NSCLC -- EGFR Exon 20
GRACEcast- ASCO LUNG 2020- Enhertu and the Potential for Treatment of HER2 Positive NSCLC 28.04.2021 9:41
Drs. H. Jack West, Helena Yu and David Spigel discuss Enhertu and the Potential for Treatment of HER2 Positive NSCLC.
GRACEcast- ASCO LUNG 2020- The SINDAS Trial - The Addition of SBRT to a Systemic EGFR inhibitor TKI in EGFR positive NSCLC 21.04.2021 13:31
Drs. H. Jack West, Helena Yu and David Spigel discuss The SINDAS Trial - The Addition of SBRT to a Systemic EGFR inhibitor TKI in EGFR positive NSCLC
GRACEcast- ASCO LUNG 2020- New Potential Treatments for MET and RET Positive NSCLC Capmatinib-Tabrecta and BLU-667-Pralsetinib 14.04.2021 10:19
Drs. H. Jack West, David Spigel and Helena Yu discuss new potenteial treatments for MET and RET Positive NSCLC: Capmatinib/Tabrecta and BLU-667/Pralsetinib
GRACECast - LCVL Can EGFR inhibitor therapy treat and prevent brain metastases 31.03.2021 8:58
Dr. H. Jack West discusses if EGFR Inhibitor therapy can treat and prevent brain metastases
GRACECast - LCVL- What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib 24.03.2021 5:42
Dr. Caroline McCoach discusses What are the options after a patient with an ALK-positive advanced NSCLC develops resistance on Alecensa-alectinib
GRACECast - LCVL - Can immunotherapy help frail patients with advanced NSCLC 17.03.2021 5:24
Dr. Matthew Gubens discusses Can immunotherapy help frail patients with advanced NSCLC
GRACECast - LCVL What is the role of immunotherapy for unresectable Stage 3 NSCLC today 12.03.2021 3:47
GRACECast - LCVL Dr. Millie Das discusses What is the role of immunotherapy for unresectable Stage 3 NSCLC today
GRACECast - LCVL - H. Jack West MD - Can ALK inhibitors treat and prevent brain metastases 12.03.2021 7:41
Dr. Howard Jack West discusses ALK Rearrangement-Positive NSCLC and if ALK inhibitors treat and prevent brain metastases?
GRACECast - LCVL - Can blood-based mutation-testing help shape treatment decisions for advanced NSCLC 24.02.2021 7:40
Dr. Heather Wakelee discusses whether blood-based mutation-testing can help shape treatment decisions for advanced NSCLC.
GRACECast - LCVL - Consolidation immunotherapy after chemo-radiation for stage 3 unresectable NSCLC 17.02.2021 7:55
Dr. Heather Wakelee discusses which patients should receive consolidation immunotherapy after chemo radiation for stage 3 unresectable non small cell lung cancer.
GRACECast - LCVL -Can local therapies improve outcomes for stage IV NSCLC? 16.02.2021 8:09
Dr. H. Jack West discusses if local therapies improve outcomes for patients with stage IV NSCLC who have a very good response to first line systemic therapy
GRACECast - LCVL - Could pre-operative immunotherapy improve outcomes in early stage NSCLC 03.02.2021 9:29
Dr. Joel Neal discusses pre-operative immunotherapy and if it could improve outcomes in early stage NSCLC. Why trials are looking at this approach.
GRACECast - LCVL - Leading treatment options for patients with low or negative tumor PD-L1 expression and advanced nonsquamous NSCLC today 27.01.2021 8:39
Dr. Millie Das discusses the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced nonsquamous NSCLC today.
GRACECast - LCVL - Can patients with an EGFR mutation-positive advanced NSCLC benefit from immunotherapy 20.01.2021 10:39
Dr. Dr. Joel Neal discusses patients with an EGFR mutation positive advanced non small cell lung cancer and if they can benefit from immunotherapy.
GRACEcast - LCVL - What are the leading first line treatment options for advanced NSCLC harboring an ALK rearrangement today 30.12.2020 4:37
Dr. Caroline McCoach discusses ALK Rearrangement-Positive NSCLC and the leading first line treatment options for advanced NSCLC harboring an ALK rearrangement today
GRACEcast - LCVL - Can immunotherapy help patients with small cell lung cancer 23.12.2020 11:05
Dr. Joel Neal discusses Small Cell Lung Cancer and whether or not immunotherapy can help patients with small cell lung cancer
GRACEcast - LCVL - Leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today 16.12.2020 6:52
Dr. Matthew Gubens discusses Targeted therapies in NSCLC PD-L1 Expression and the leading treatment options for patients with low or negative tumor PD-L1 expression and advanced squamous NSCLC today
GRACEcast - LCVL - What is the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today 09.12.2020 6:31
Dr. Jonathan Reiss discusses EGFR Mutation and the best first line treatment for patients with advanced EGFR mutation-positive NSCLC today
GRACEcast - LCVL - Which patients with advanced NSCLC are good candidates for first line immunotherapy alone today 02.12.2020 9:26
Dr H. Jack West discusses Immunotherapy in NSCLC, and which patients with advanced NSCLC are good candidates for first line immunotherapy alone today?
GRACEcast - LCVL What is the current standard of care for patients with extensive stage small cell lung cancer 25.11.2020 5:58
Dr. Jonathan Reiss discusses the current standard of care for patients with extensive stage small cell lung cancer.
Similar podcasts
Listen to the GRACEcast - Discussions with the Global Resource for Advancing Cancer Education podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
